Background: Glucagon-like peptide-1 (GLP-1) agonists are increasingly prescribed for obesity and type 2 diabetes, demonstrating efficacy in weight loss and glycemic control [1-3]. Beyond metabolic effects, these medications show protective effects against renal disease progression and reduce major adverse cardiovascular events [4]. GLP-1 agonists influence body composition through effects on both fat mass and fat-free [...]

Background: The low-density lipoprotein cholesterol (LDL-C) might be protective in patients with sepsis. We sought to characterize potential association of hyperlipidemia (HLP) vs no HLP with all-cause mortality among patients hospitalized for pneumonia. Methods: This is a retrospective observational study. The initial cohort consisted of consecutive 8,553 adults hospitalized at a large academic center with [...]

Background: Glucagon-like peptide-1 (GLP-1) agonists are increasingly prescribed for obesity and type 2 diabetes, demonstrating efficacy in weight loss and glycemic control [1-3]. Beyond metabolic effects, these medications show protective effects against renal disease progression and reduce major adverse cardiovascular events [4]. GLP-1 agonists influence body composition through effects on both fat mass and fat-free [...]